Cite
HARVARD Citation
Marynissen, H. et al. (2022). First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan. Clinical and translational science. 15 (8), pp. 1968-1977. [Online].